Citations (23)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Dorothée Lulé, Albert C. Ludolph & Jan Kassubek. (2009) MRI-based functional neuroimaging in ALS: An update. Amyotrophic Lateral Sclerosis 10:5-6, pages 258-268.
Read now
Read now
Articles from other publishers (22)
Yuanshuai Zhou, Zhongjuan Xu, Yanzhen Yu, Junjun Cao, Yong Qiao, Hong Qiao & Guangli Suo. (2019) Comprehensive analysis of the lncRNA-associated ceRNA network identifies neuroinflammation biomarkers for Alzheimer's disease. Molecular Omics 15:6, pages 459-469.
Crossref
Crossref
Hong Li, Sue Leurgans, Jordan Elm & Mulugeta Gebregziabher. (2019) Statistical Methodology for Multiclass Classifications: Applications to Dementia. Journal of Alzheimer's Disease 68:1, pages 173-186.
Crossref
Crossref
Raúl González-Domínguez, Antonia García, Tamara García-Barrera, Coral Barbas & José Luis Gómez-Ariza. (2014) Metabolomic profiling of serum in the progression of Alzheimer's disease by capillary electrophoresis-mass spectrometry. ELECTROPHORESIS 35:23, pages 3321-3330.
Crossref
Crossref
Takashi Kozaka, Izumi Uno, Yoji Kitamura, Daisuke Miwa, Mohammad Anwar-Ul Azim, Kazuma Ogawa & Kazuhiro Shiba. (2014)
Regional brain imaging of vesicular acetylcholine transporter using
o
-[
125
I]iodo-
trans
-decalinvesamicol as a new potential imaging probe
. Synapse 68:3, pages 107-113.
Crossref
Crossref
Chantal Bazenet & Simon Lovestone. (2012) Plasma biomarkers for Alzheimer’s disease: much needed but tough to find. Biomarkers in Medicine 6:4, pages 441-454.
Crossref
Crossref
Maxime Parent, Marc-Andre Bedard, Antonio Aliaga, Jean-Paul Soucy, Evelyne Landry St-Pierre, Marilyn Cyr, Alexey Kostikov, Esther Schirrmacher, Gassan Massarweh & Pedro Rosa-Neto. (2012) PET imaging of cholinergic deficits in rats using [18F]fluoroethoxybenzovesamicol ([18F]FEOBV). NeuroImage 62:1, pages 555-561.
Crossref
Crossref
Yoshiaki Sato, Ikumi Suzuki, Tatsuji Nakamura, Francois Bernier, Ken Aoshima & Yoshiya Oda. (2012) Identification of a new plasma biomarker of Alzheimer's disease using metabolomics technology. Journal of Lipid Research 53:3, pages 567-576.
Crossref
Crossref
Igor Yakushev, Alex Gerhard, Matthias J. Müller, Markus Lorscheider, Hans-Georg Buchholz, Ingrid Schermuly, Carsten Weibrich, Alexander Hammers, Peter Stoeter, Matthias Schreckenberger & Andreas Fellgiebel. (2011) Relationships between hippocampal microstructure, metabolism, and function in early Alzheimer’s disease. Brain Structure and Function 216:3, pages 219-226.
Crossref
Crossref
Gábor Juhász, István Földi & Botond Penke. (2011) Systems biology of Alzheimer's disease: How diverse molecular changes result in memory impairment in AD. Neurochemistry International 58:7, pages 739-750.
Crossref
Crossref
Yoshiaki Sato, Tatsuji Nakamura, Ken Aoshima & Yoshiya Oda. (2010) Quantitative and Wide-Ranging Profiling of Phospholipids in Human Plasma by Two-dimensional Liquid Chromatography/Mass Spectrometry. Analytical Chemistry 82:23, pages 9858-9864.
Crossref
Crossref
J Scott Roberts & Sarah M Tersegno. (2010) Estimating and disclosing the risk of developing Alzheimer’s disease: challenges, controversies and future directions. Future Neurology 5:4, pages 501-517.
Crossref
Crossref
André Schrattenholz, Karlfried Groebe & Vukic Soskic. 2010. Systems Biology in Drug Discovery and Development. Systems Biology in Drug Discovery and Development
29
58
.
You-Jun Fu, Shuling Xiong, Mark A. Lovell & Bert C. Lynn. (2009) Quantitative Proteomic Analysis of Mitochondria in Aging PS-1 Transgenic Mice. Cellular and Molecular Neurobiology 29:5, pages 649-664.
Crossref
Crossref
Marcel Ferrer-Alcón, David Arteta, M.ª José Guerrero, Dietmar Fernandez-Orth, Laureano Simón & Antonio Martinez. (2009) The use of gene array technology and proteomics in the search of new targets of diseases for therapeutics. Toxicology Letters 186:1, pages 45-51.
Crossref
Crossref
C. C. Gispen-De Wied, M. Kritsidima & A. J. A. Elferink. (2009) The validity of biomarkers as surrogate endpoints in Alzheimer’s disease by means of the Quantitative Surrogate Validation Level of Evidence Scheme (QSVLES). The Journal of Nutrition, Health and Aging 13:4, pages 376-387.
Crossref
Crossref
Nicola Greenberg, Antonio Grassano, Madhav Thambisetty, Simon Lovestone & Cristina Legido-Quigley. (2009) A proposed metabolic strategy for monitoring disease progression in Alzheimer's disease. ELECTROPHORESIS 30:7, pages 1235-1239.
Crossref
Crossref
Khin Than Myint, Ken Aoshima, Satoshi Tanaka, Tatsuji Nakamura & Yoshiya Oda. (2009) Quantitative Profiling of Polar Cationic Metabolites in Human Cerebrospinal Fluid by Reversed-Phase Nanoliquid Chromatography/Mass Spectrometry. Analytical Chemistry 81:3, pages 1121-1129.
Crossref
Crossref
Weiping Qin, Lap Ho, Jun Wang, Elaine Peskind & Giulio Maria Pasinetti. (2009) S100A7, a Novel Alzheimer's Disease Biomarker with Non-Amyloidogenic α-Secretase Activity Acts via Selective Promotion of ADAM-10. PLoS ONE 4:1, pages e4183.
Crossref
Crossref
Michael S. Ritsner & Irving I. Gottesman. 2009. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes. The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes
3
21
.
Ivan R. Baxter, Olga Vitek, Brett LahnerBalasubramaniam MuthukumarMonica BorghiJoe Morrissey, Mary Lou Guerinot & David E. Salt. (2008) The leaf ionome as a multivariable system to detect a plant's physiological status. Proceedings of the National Academy of Sciences 105:33, pages 12081-12086.
Crossref
Crossref
. (2008) Current awareness in geriatric psychiatry. International Journal of Geriatric Psychiatry 23:5.
Crossref
Crossref
Alan Lyles. (2008) Alzheimer's disease: The specter of fragmented policy and financing. Clinical Therapeutics 30:1, pages 192-194.
Crossref
Crossref